Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Endocrinology · Isolated ACTH Deficiency

Decoding Your Labs: The Path to an Accurate Diagnosis

At a Glance

Isolated ACTH deficiency is assessed with paired early-morning cortisol and ACTH tests, followed when needed by cosyntropin stimulation or specialist dynamic testing. A normal early cosyntropin result may not exclude recent-onset disease, so endocrinology follow-up is important.

Diagnosing isolated ACTH deficiency (IAD) is a multi-step process that requires careful timing and interpretation. Because the pituitary gland’s hormone levels fluctuate throughout the day, the results of a single blood test are rarely enough to provide a complete picture [1][2]. Never stop, skip, or change your steroid medicines to prepare for testing unless the ordering clinician gives you explicit instructions to do so.

The Starting Point: Morning Paired Labs

The first step is usually an 8:00 AM blood draw to measure two hormones at the same time: cortisol and ACTH.

  • The Cortisol Anchor: In a healthy body, cortisol is at its highest in the morning. If your 8:00 AM cortisol is very low (typically below approximately 3 µg/dL, though assay thresholds vary), it strongly suggests adrenal insufficiency [1][2]. Values above a higher, assay-dependent threshold may make it unlikely, while intermediate results require dynamic testing.
  • The ACTH Pitfall: Doctors look for ACTH to be “inappropriately normal.” Normally, if cortisol is low, a healthy pituitary gland will flood the body with ACTH to fix it [3]. If your cortisol is low but your ACTH is still “within the normal range,” it means your pituitary gland is failing to respond to the crisis. This “normal” result is actually abnormal when paired with the low cortisol [3][4].

The Challenge of Recent-Onset Disease

The most common diagnostic tool is the cosyntropin stimulation test (also called a Synacthen test). In this test, you receive an injection of synthetic ACTH to see if your adrenal glands can still produce cortisol [5].

However, this test has a major blind spot: it can be falsely normal in the early stages of IAD [6][7]. Because the test injects ACTH directly into your blood, your adrenal glands may still respond perfectly even if your pituitary hasn’t sent them a signal in days or weeks [7][8]. It takes time (often weeks or months) for the adrenal glands to “shrink” (atrophy) from lack of use. If your symptoms are brand new, a normal stimulation test does not rule out the condition [9][6].

Moving to Specialist Tests

If your morning labs and stimulation tests are inconclusive but your symptoms remain, your doctor may consider more intensive “dynamic” tests to check the entire communication line between your brain and your adrenal glands.

  1. Insulin Tolerance Test (ITT): Considered a reference standard in specialist centers for central adrenal insufficiency [10]. Doctors use insulin to safely lower your blood sugar, which should trigger a massive stress response and a surge of cortisol. If your body doesn’t react, the deficiency is confirmed [11]. Because it involves low blood sugar, this test requires close medical supervision and is not safe for everyone, such as those with heart disease or seizures [6].
  2. Metyrapone Test: This test uses a medication to temporarily block cortisol production, forcing the pituitary to work harder [12]. Doctors then measure a precursor called 11-deoxycortisol. If that precursor stays low, it proves the pituitary is not sending the signal to make more [13][14]. (Note that these tests belong in the hands of an endocrinologist and are not universally required).

Evaluating the Deficiency

To check the status of your pituitary, your doctor will check the other “departments” of your gland. This includes testing:

  • Thyroid-Stimulating Hormone (TSH) and Free T4 to check your thyroid [15].
  • Gonadotropins (LH and FSH) and sex hormones to check reproductive hormones [16].
  • IGF-1 levels as a screening test for growth hormone [17].
  • Prolactin levels [15].

If all these other hormones are normal, it suggests the condition is currently isolated, though interpretation is highly individualized based on age, sex, and medications [18].

Central vs. Primary: Spotting the Difference

It is vital to distinguish IAD (a “central” or pituitary problem) from Addison’s Disease (a “primary” or adrenal problem) [19].

Feature Central (IAD) Primary (Addison’s)
ACTH Levels Low or “Inappropriately Normal” [3] Very High [19]
Aldosterone Usually Normal (Preserved) [20] Low [19]
Potassium Usually Normal [21] Often High [22]
Treatment Hydrocortisone only [23] Hydrocortisone + Fludrocortisone [20]

In IAD, your body can still balance its salt and blood pressure because the hormone aldosterone is controlled primarily by the renin-angiotensin system, not your pituitary. This is why most IAD patients do not need the extra salt-balancing medication (fludrocortisone) that patients with Addison’s require [20][23].

Note: While aldosterone is usually normal, you may still experience low sodium (hyponatremia) due to the lack of cortisol, so monitoring electrolyte levels is still a key part of your care [24][21].

Common questions in this guide

What does an “inappropriately normal” ACTH result mean when cortisol is low?
When cortisol is low, a healthy pituitary gland should release a high amount of ACTH. If ACTH is only within the normal range or low despite low cortisol, it is “inappropriately normal” and can indicate that the pituitary is not sending enough signal to the adrenal glands.
Can a normal cosyntropin test miss early isolated ACTH deficiency?
Yes. Cosyntropin supplies synthetic ACTH directly, and the adrenal glands may still make cortisol for a while after the pituitary stops signaling them. Because adrenal shrinkage takes time, a normal early result may not rule out recent-onset isolated ACTH deficiency when symptoms and other results remain concerning.
What tests are used when morning cortisol and cosyntropin results are inconclusive?
An endocrinologist may consider an insulin tolerance test or a metyrapone test to assess the full pituitary-adrenal response. These are specialist tests: the insulin test causes low blood sugar and requires close supervision, and it may be unsafe for people with certain conditions such as heart disease or seizures. They are not necessary or appropriate for everyone.
How is isolated ACTH deficiency different from Addison’s disease?
Isolated ACTH deficiency is a central problem involving the pituitary, so ACTH is low or inappropriately normal and aldosterone is usually preserved. Addison’s disease is a primary adrenal problem, typically with very high ACTH, low aldosterone, and higher potassium. The treatment plan can differ, so clinicians use hormone and electrolyte results to distinguish them.
How do doctors confirm that ACTH deficiency is truly isolated?
They check other pituitary-controlled hormones, including TSH and free T4, LH and FSH with sex hormones, IGF-1, and prolactin. Normal results support an isolated ACTH-cortisol problem, but interpretation depends on factors such as age, sex, and medications.
Will I need fludrocortisone if I have isolated ACTH deficiency?
Usually, aldosterone production is preserved in isolated ACTH deficiency, so many patients need hydrocortisone without fludrocortisone. Your clinician should review aldosterone, renin, sodium, potassium, blood pressure, and the overall diagnosis before deciding on treatment.
Can steroid medicines affect ACTH and cortisol testing?
Yes. Steroids from creams, joint injections, inhalers, mouthwashes, or other medicines can affect test results. Tell the ordering clinician about all steroid exposure, and do not stop, skip, or change prescribed steroids unless you are explicitly told to do so.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Late-onset isolated ACTH deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Were my cortisol and ACTH levels measured at the same time in the morning, and can you explain what an 'inappropriately normal' ACTH result means for me?
  2. 2.Given how recently my symptoms started, is it possible the cosyntropin test was normal because my adrenal glands haven't had time to react to the lack of ACTH yet?
  3. 3.Since my first tests were inconclusive, would you recommend an Insulin Tolerance Test (ITT) or a Metyrapone test as a more definitive 'gold standard' for me?
  4. 4.What specific hormone levels (like TSH, T4, or sex hormones) did you check to confirm that my deficiency is truly 'isolated' to the ACTH-cortisol pathway?
  5. 5.Do my labs show that my aldosterone and renin levels are normal? Does this mean I only need to take hydrocortisone and not fludrocortisone?

References

References (24)
  1. 1

    DIAGNOSTIC ACCURACY OF BASAL CORTISOL LEVEL TO PREDICT ADRENAL INSUFFICIENCY IN COSYNTROPIN TESTING: RESULTS FROM AN OBSERVATIONAL COHORT STUDY WITH 804 PATIENTS.

    Struja T, Briner L, Meier A, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017; (23(8)):949-961 doi:10.4158/EP171861.OR.

    PMID: 28614010
  2. 2

    Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment.

    Ceccato F, Scaroni C

    Clinical chemistry and laboratory medicine 2019; (57(8)):1125-1135.

    PMID: 30427776
  3. 3

    Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis.

    Chanson P, Guignat L, Goichot B, et al.

    Annales d'endocrinologie 2017; (78(6)):495-511 doi:10.1016/j.ando.2017.10.005.

    PMID: 29174200
  4. 4

    Clinical features and thyroid dysfunction in adverse events involving the pituitary gland during PD-1 blockade therapy.

    Yamauchi I, Taura D, Hakata T, et al.

    Clinical endocrinology 2021; (94(2)):258-268 doi:10.1111/cen.14349.

    PMID: 33037658
  5. 5

    New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays.

    Javorsky BR, Raff H, Carroll TB, et al.

    Journal of the Endocrine Society 2021; (5(4)):bvab022 doi:10.1210/jendso/bvab022.

    PMID: 33768189
  6. 6

    Potential pitfalls in diagnosis of immunotherapy-induced hypothalamic-pituitary-adrenal axis abnormalities: a clinical case.

    Bi Y, Adam S, Chatzimavridou V, et al.

    Endocrine oncology (Bristol, England) 2022; (2(1)):K5-K9 doi:10.1530/EO-21-0023.

    PMID: 37435468
  7. 7

    Acute-Onset Panhypopituitarism Nearly Missed by Initial Cosyntropin Testing.

    Blum CA, Schneeberger D, Lang M, et al.

    Case reports in critical care 2017; (2017()):7931438 doi:10.1155/2017/7931438.

    PMID: 29109870
  8. 8

    Central adrenal insufficiency following traumatic brain injury: a missed diagnosis in the critically injured.

    Fan E, Skippen PW, Sargent MA, et al.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2017; (33(12)):2205-2207 doi:10.1007/s00381-017-3536-5.

    PMID: 28721596
  9. 9

    ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis.

    Ospina NS, Al Nofal A, Bancos I, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(2)):427-34 doi:10.1210/jc.2015-1700.

    PMID: 26649617
  10. 10

    ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow.

    Birtolo MF, Antonini S, Saladino A, et al.

    Biomedicines 2023; (11(3)) doi:10.3390/biomedicines11030904.

    PMID: 36979883
  11. 11

    SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.

    Reznik Y, Barat P, Bertherat J, et al.

    Annales d'endocrinologie 2018; (79(1)):1-22 doi:10.1016/j.ando.2017.12.001.

    PMID: 29338844
  12. 12

    Use of overnight metyrapone test in suspected secondary adrenal insufficiency: A retrospective single centre-study.

    Saini J, Garcia RG, Herndon J, et al.

    Clinical endocrinology 2024; (100(3)):203-211 doi:10.1111/cen.14989.

    PMID: 37997487
  13. 13

    Evaluation of plasma ACTH in the metyrapone test is insufficient for the diagnosis of secondary adrenal insufficiency.

    Papierska L, Rabijewski M, Migda B, et al.

    Frontiers in endocrinology 2022; (13()):1004129 doi:10.3389/fendo.2022.1004129.

    PMID: 36440206
  14. 14

    11-deoxycortisol, other hormones and pituitary function characteristics in the diagnosis of adrenal insufficiency in the overnight oral metyrapone test.

    Krawzow A, Peitzsch M, Bastian M, et al.

    Endocrine connections 2026; (15(8)) doi:10.1530/EC-26-0261.

    PMID: 42525124
  15. 15

    Hypopituitarism.

    Higham CE, Johannsson G, Shalet SM

    Lancet (London, England) 2016; (388(10058)):2403-2415 doi:10.1016/S0140-6736(16)30053-8.

    PMID: 27041067
  16. 16

    Isolated anterior pituitary dysfunction in adulthood.

    Prencipe N, Marinelli L, Varaldo E, et al.

    Frontiers in endocrinology 2023; (14()):1100007 doi:10.3389/fendo.2023.1100007.

    PMID: 36967769
  17. 17

    Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease.

    Van Mieghem E, De Block C, De Herdt C

    Pituitary 2024; (27(1)):23-32 doi:10.1007/s11102-023-01366-9.

    PMID: 38151529
  18. 18

    One Case of Sudden Isolated Adrenocorticotropic Hormone (ACTH) Deficiency Diagnosed Based on Repeated Hypoglycemic Attacks.

    Sato T

    Cureus 2025; (17(6)):e86185 doi:10.7759/cureus.86185.

    PMID: 40677481
  19. 19

    Latent Adrenal Insufficiency: From Concept to Diagnosis.

    Younes N, Bourdeau I, Lacroix A

    Frontiers in endocrinology 2021; (12()):720769 doi:10.3389/fendo.2021.720769.

    PMID: 34512551
  20. 20

    Adrenal Failure: An Evidence-Based Diagnostic Approach.

    Shaikh S, Nagendra L, Shaikh S, Pappachan JM

    Diagnostics (Basel, Switzerland) 2023; (13(10)) doi:10.3390/diagnostics13101812.

    PMID: 37238296
  21. 21

    Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review.

    Hinata Y, Ohara N, Sakurai Y, et al.

    The American journal of case reports 2021; (22()):e931639 doi:10.12659/AJCR.931639.

    PMID: 34262010
  22. 22

    Primary adrenal insufficiency in children: Diagnosis and management.

    Kirkgoz T, Guran T

    Best practice & research. Clinical endocrinology & metabolism 2018; (32(4)):397-424 doi:10.1016/j.beem.2018.05.010.

    PMID: 30086866
  23. 23

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647
  24. 24

    Clinical features and autoimmune associations in patients presenting with Idiopathic Isolated ACTH deficiency.

    Hannon AM, Hunter S, Smith D, et al.

    Clinical endocrinology 2018; (88(3)):491-497 doi:10.1111/cen.13536.

    PMID: 29266367

This page explains how clinicians evaluate late-onset isolated ACTH deficiency for informational purposes only and does not constitute medical advice. Do not stop or change steroid medicines or pursue specialized testing without instructions from your healthcare professional.